These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26613030)

  • 1. Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy.
    Haruhara K; Tsuboi N; Koike K; Kanzaki G; Okabayashi Y; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Clin Kidney J; 2015 Dec; 8(6):716-21. PubMed ID: 26613030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.
    Mizerska-Wasiak M; Małdyk J; Rybi-Szumińska A; Wasilewska A; Miklaszewska M; Pietrzyk J; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Pukajło-Marczyk A; Zwolińska D; Szczepańska M; Turczyn A; Roszkowska-Blaim M
    Pediatr Nephrol; 2015 Jul; 30(7):1113-20. PubMed ID: 25549975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
    Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
    Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blind Spot in the Radar of MEST-C Score: Type and Severity of Tubulointerstitial Nephritis in IgA Nephropathy.
    Asrar I; Hussain M; Afzal A; Hassan U; Ishtiaq S
    Int J Nephrol; 2023; 2023():1060526. PubMed ID: 36950660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Oxford classification in assessing immunoglobulin A nephropathy after transplantation.
    Lim BJ; Joo DJ; Kim MS; Kim YS; Kim SI; Kim Y; Huh KH; Koh MJ; Jeong HJ
    Transplantation; 2013 Jun; 95(12):1491-7. PubMed ID: 23677050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients.
    Haruhara K; Tsuboi N; Koike K; Fukui A; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Hypertens Res; 2015 Feb; 38(2):116-22. PubMed ID: 25231252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining.
    Ştefan G; Ismail G; Stancu S; Zugravu A; Andronesi A; Mandache E; Mircescu G
    Pathol Int; 2016 Aug; 66(8):453-9. PubMed ID: 27439692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
    Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
    Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare.
    Hisano S; Joh K; Katafuchi R; Shimizu A; Hashiguchi N; Kawamura T; Matsuo S;
    Clin Exp Nephrol; 2017 Feb; 21(1):92-96. PubMed ID: 27011013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between renal CD68
    Soares MF; Genitsch V; Chakera A; Smith A; MacEwen C; Bellur SS; Alham NK; Roberts ISD
    Histopathology; 2019 Mar; 74(4):629-637. PubMed ID: 30303541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R
    Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxford-MEST classification in IgA nephropathy patients: A report from Iran.
    Nasri H; Mortazavi M; Ghorbani A; Shahbazian H; Kheiri S; Baradaran A; Emami-Naieni A; Saffari M; Mardani S; Momeni A; Madihi Y; Baradaran-Ghahfarokhi M; Rafieian-Kopaie M; Hedayati P; Baradaran S; Ardalan M; Sajjadieh S; Assarzadegan N; Ahmadi Soleimani SM; Tamadon MR
    J Nephropathol; 2012 Apr; 1(1):31-42. PubMed ID: 24475384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Oxford classification of IgA nephropathy: a retrospective analysis.
    Yau T; Korbet SM; Schwartz MM; Cimbaluk DJ
    Am J Nephrol; 2011; 34(5):435-44. PubMed ID: 21968096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil therapy in immunoglobulin A nephropathy: histological changes after treatment.
    Beckwith H; Medjeral-Thomas N; Galliford J; Griffith M; Levy J; Lightstone L; Palmer A; Roufosse C; Pusey C; Cook HT; Cairns T
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i123-i128. PubMed ID: 28391339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure, proteinuria and uric acid in children with IgA nephropathy and their correlation with histopathological findings.
    Seeman T; Pohl M; John U; Dusek J; Vondrák K; Janda J; Stejskal J; Groene HJ; Misselwitz J
    Kidney Blood Press Res; 2008; 31(5):337-42. PubMed ID: 18946224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.